BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.91B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.41B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.16B |
| 4 |
Apple
AAPL
|
+$704M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$665M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$115M |
| 2 |
iShares US Financials ETF
IYF
|
+$109M |
| 3 |
Visa
V
|
+$108M |
| 4 |
Charter Communications
CHTR
|
+$73.8M |
| 5 |
Honeywell
HON
|
+$58.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.76% |
| 2 | Healthcare | 6.75% |
| 3 | Financials | 5.74% |
| 4 | Consumer Discretionary | 5.28% |
| 5 | Communication Services | 4.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
CALL
Canadian Natural Resources
CNQ
$99.5B
| $249K | ﹤0.01% |
+376
| New | +$4.48K |
|
|
AVTA
2602
DELISTED
Avantax, Inc. Common Stock
AVTA
| $248K | ﹤0.01% |
20,591
+5,436
| +36% | +$105K |
|
|
KRTX
2603
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $248K | ﹤0.01% |
3,444
+2,912
| +547% | +$249K |
|
2604
Artivion
AORT
$1.41B
| $248K | ﹤0.01% |
14,648
+6,352
| +77% | +$163K |
|
2605
Visteon
VC
$2.84B
| $248K | ﹤0.01% |
5,164
-6,958
| -57% | -$505K |
|
2606
Stewart Information Services
STC
$2.07B
| $248K | ﹤0.01% |
9,289
+72
| +0.8% | +$2.65K |
|
2607
Stride
LRN
$3.46B
| $248K | ﹤0.01% |
13,127
-42,520
| -76% | -$784K |
|
2608
TriCo Bancshares
TCBK
$1.85B
| $247K | ﹤0.01% |
8,283
+1,587
| +24% | +$55.5K |
|
|
BLDP
2609
Ballard Power Systems
BLDP
$811M
| $247K | ﹤0.01% |
32,453
-136,771
| -81% | -$1.33M |
|
|
ATNX
2610
DELISTED
Athenex, Inc. Common Stock
ATNX
| $247K | ﹤0.01% |
1,594
+1,192
| +297% | +$300K |
|
|
MTOR
2611
PUT
DELISTED
MERITOR, Inc.
MTOR
| $246K | ﹤0.01% |
+186
| New | +$4.01K |
|
2612
Columbia Financial
CLBK
$1.22B
| $246K | ﹤0.01% |
17,092
+3,338
| +24% | +$53.4K |
|
2613
Icon
ICLR
$12.7B
| $245K | ﹤0.01% |
1,801
-4,417
| -71% | -$707K |
|
|
SASR
2614
DELISTED
Sandy Spring Bancorp Inc
SASR
| $243K | ﹤0.01% |
10,747
+6,621
| +160% | +$211K |
|
2615
Triumph Financial Inc
TFIN
$1.88B
| $242K | ﹤0.01% |
9,323
+4,071
| +78% | +$141K |
|
2616
Dave & Buster's
PLAY
$359M
| $241K | ﹤0.01% |
18,416
+8,610
| +88% | +$295K |
|
2617
The Greenbrier Companies
GBX
$1.42B
| $241K | ﹤0.01% |
13,557
+191
| +1% | +$4.53K |
|
2618
Amneal Pharmaceuticals
AMRX
$6.16B
| $240K | ﹤0.01% |
68,939
+20,386
| +42% | +$86.3K |
|
2619
New York Times
NYT
$10.5B
| $240K | ﹤0.01% |
7,803
-29,351
| -79% | -$1.01M |
|
|
RWT
2620
Redwood Trust
RWT
$603M
| $239K | ﹤0.01% |
47,215
+2,904
| +7% | +$43.2K |
|
|
CPE
2621
DELISTED
Callon Petroleum Company
CPE
| $238K | ﹤0.01% |
43,485
-24,983
| -36% | -$615K |
|
2622
PUT
Vertex Pharmaceuticals
VRTX
$129B
| $238K | ﹤0.01% |
10
-481
| -98% | -$110K |
|
|
FOCS
2623
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $237K | ﹤0.01% |
10,313
+5,021
| +95% | +$133K |
|
2624
Avantor
AVTR
$9.31B
| $237K | ﹤0.01% |
18,988
-3,280
| -15% | -$52.6K |
|
2625
Unitil
UTL
$991M
| $237K | ﹤0.01% |
4,527
+537
| +13% | +$31.8K |
|
Similar funds
BNP Paribas Financial Markets's Q1 2020 Portfolio in Review
As of Q1 2020, BNP Paribas Financial Markets held 4,585 positions worth $48.8B, down 11% from $54.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
BNP Paribas Financial Markets deployed $12.8B of net new capital in Q1 2020, opening 132 new positions and adding to 2,502 existing holdings. Its largest new stake was iShares 0-1 Year Treasury Bond ETF: 132,067 shares worth $14.7M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 7.9% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Pfizer, an estimated $115M trimmed.
- BNP Paribas Financial Markets's largest Q1 2020 buy was iShares 0-1 Year Treasury Bond ETF: 132,067 shares worth $14.7M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q1 2020, an estimated $2.91B increase.
- BNP Paribas Financial Markets's biggest Q1 2020 reduction was Pfizer, cutting an estimated $115M.
- BNP Paribas Financial Markets fully exited State Street SPDR S&P Health Care Equipment ETF in Q1 2020, selling an estimated $47.1M.
- BNP Paribas Financial Markets's ten largest holdings make up 21% of its $48.8B portfolio in Q1 2020.
- BNP Paribas Financial Markets opened 132 new positions and closed 257 in Q1 2020.
- BNP Paribas Financial Markets's portfolio value fell 11% quarter-over-quarter to $48.8B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2020, filed 13 May 2020.